Skip to main content

Carlos A. Tristan, Ph.D., M.S.


Division of Preclinical Innovation

Stem Cell Translation Laboratory

Contact Info

Portrait of Carlos A. Tristan


Carlos A. Tristan, Ph.D., M.S, is the director of the Stem Cell Translation Laboratory (SCTL) within NCATS’ Division of Preclinical Innovation. Tristan works on leveraging multi-omic technologies to develop and optimize human pluripotent stem cell (hPSC) culture maintenance and differentiation protocols to accelerate the translational application of hPSC-derived cells in disease modeling, regenerative therapy and drug discovery.

Tristan joined the SCTL in 2016, serving as a staff scientist and helping to establish chemical, robotic, high-throughput and multi-omic platforms to address current hurdles in the hPSC field. Prior to joining NCATS, Tristan conducted his postdoctoral work at the Radiation Oncology Branch of the National Cancer Institute’s Center for Cancer Research in Bethesda, Maryland, where he focused on understanding the molecular mechanisms of tumor-initiating cells in glioblastoma multiforme.

Tristan earned his Ph.D. in cellular and molecular medicine from the Johns Hopkins University School of Medicine, where he worked in the Department of Psychiatry and Behavioral Sciences under Akira Sawa, M.D., Ph.D., to uncover novel signaling mechanisms and crosstalk among cell stress-signaling cascades. Tristan earned his M.S. in biology and two Bachelor’s degrees in chemistry and biology from California State University in Fresno, California.

Research Topics

Tristan is interested in advancing the use of hPSC technologies in disease modeling, drug discovery, therapeutic development and clinical applications.

Last updated on March 12, 2024